1-6 of 6
Chun Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A089: NST-628 is a potent, fully brain-penetrant, RAS/MAPK pathway molecular glue inhibitor with efficacy in CNS tumor models

Meagan B Ryan, Chun Li, Yongxin Han, Klaus P Hoeflich, Michael R Hale, Margit Hagel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): A089.
https://doi.org/10.1158/1535-7163.TARG-23-A089
Published: 01 December 2023
View article titled, Abstract A089: NST-628 is a potent, fully brain-penetrant, RAS/MAPK pathway molecular glue inhibitor with efficacy in CNS tumor models
Journal Articles

Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma

Chia-Wen Liu, Kuo-Tai Hua, Kai-Chun Li, Hsiang-Fong Kao, Ruey-Long Hong, Jenq-Yuh Ko, Michael Hsiao, Min-Liang Kuo, Ching-Ting Tan
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (7): 1421–1434.
https://doi.org/10.1158/1535-7163.MCT-16-0567-T
Published: 04 July 2017
View article titled, Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
Open the PDF for Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract A142: The effect of beta2-glycoprotein I on anti-tumor cell migration

An-Na Chiang, Wan-Chun Li, Shu-Hau Yeh, Shu-Wei Cheng, Yu-Shan Lin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A142.
https://doi.org/10.1158/1535-7163.TARG-15-A142
Published: 01 December 2015
View article titled, Abstract A142: The effect of beta2-glycoprotein I on anti-tumor cell migration
Journal Articles

Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity

Yu Cao, James D. Marks, Qian Huang, Stephen I. Rudnick, Chiyi Xiong, Walter N. Hittelman, Xiaoxia Wen, John W. Marks, Lawrence H. Cheung, Kim Boland, Chun Li, Gregory P. Adams, Michael G. Rosenblum
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (1): 143–153.
https://doi.org/10.1158/1535-7163.MCT-11-0519
Published: 09 January 2012
View article titled, Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity
Open the PDF for Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity in another window
Includes: Supplementary data
Journal Articles

In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy

Marites P. Melancon, Wei Lu, Zhi Yang, Rui Zhang, Zhi Cheng, Andrew M. Elliot, Jason Stafford, Tammy Olson, Jin Z. Zhang, Chun Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (6): 1730–1739.
https://doi.org/10.1158/1535-7163.MCT-08-0016
Published: 19 June 2008
View article titled, <em>In vitro</em> and <em>in vivo</em> targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy
Open the PDF for <em>In vitro</em> and <em>in vivo</em> targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy in another window
Journal Articles

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition

Seung-Hyun Oh, Ok-Hee Lee, Claudia P. Schroeder, Yun W. Oh, Shi Ke, Hee-Jae Cha, Rang-Woon Park, Amir Onn, Roy S. Herbst, Chun Li, Ho-Young Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (11): 2685–2695.
https://doi.org/10.1158/1535-7163.MCT-06-0142
Published: 22 November 2006
View article titled, Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition
Open the PDF for Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor–independent urokinase-type plasminogen activator inhibition in another window